Antibiotic | Phenotype (MIC μg/L) |  | Resistance Genes and Mutations in ST772-MRSA-V | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
 | DAR4145 |  | DAR4145 | 07-17048 | KT/Y21 | 118 | 120 | 333 | 3957 | 3989 | LVP2 | VH60 |
Oxacillin | R (≥4) | mecA (M) | + | + | + | + | + | + | + | + | + | + |
blaZ (M) | + | + | + | + | + | + | + | + | + | + | ||
blaZ (P) | + | - | + | + | +/− | - | - | + | + | + | ||
Gentamicin | R (≥16) | aacA-aphD (M) | + | + | + | - | + | + | + | + | + | + |
aphA-III, sat4, aadE(p) (P) | + | + | + | +/− | + | - | - | + | + | + | ||
Trimethoprim/Sulfamethoxazole | R (≥320) | dfrA (C) | + | + | + | + | + | + | + | + | + | + |
dfrG (C) | + | - | - | - | + | + | - | + | + | + | ||
dfrG (M) | + | + | + | + | - | - | + | - | - | - | ||
Ciprofloxacin Levofloxacin Moxifloxacin | R (4) R (4) I (1) | norA/norB (C) | + | + | + | + | + | + | + | + | + | + |
grlA (S80T/F) | + | + | + | + | + | + | + | + | + | + | ||
gyrA (S84L) | + | + | + | + | + | + | + | + | + | + | ||
Tetracyline | S (≤1) | tet(38) (C) | + | + | + | + | + | + | + | + | + | + |
Erythromicin Clindamycin | I (1) S ( ≤0.25) | msrA-mphC (P) | + | + | + | + | + | - | - | + | + | + |